Results 161 to 170 of about 13,819 (183)

Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level

Mycoses, 2020
Jihyu Oh, Cheol-in Kang, Si-ho Kim
exaly  

Pharmacokinetics of Oral Posaconazole in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Graft-versus-Host Disease

Pharmacotherapy, 2007
Pranatharthi Chandrasekar, Andrew J Ullmann   +1 more
exaly  

Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis

Mycoses, 2015
Marisa H Miceli, Bernard L Marini, Anthony J Perissinotti   +2 more
exaly  

Effect of Oral Posaconazole on the Pharmacokinetics of Cyclosporine and Tacrolimus

Pharmacotherapy, 2007
Arturo Iglesias, Víctor M Cruz-atienza
exaly  

Review of the New Delayed-Release Oral Tablet and Intravenous Dosage Forms of Posaconazole

Pharmacotherapy, 2015
Douglas Slain
exaly  

Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis

Mycoses, 2013
Werner J Heinz
exaly  

Posaconazole: an emerging therapeutic option for invasive rhino‐orbito‐cerebral mucormycosis

Mycoses, 2016
Abi Manesh, Lalee Varghese, Vedantam Rupa   +2 more
exaly